ArticleJournal of virology2001
Functional roles of equine infectious anemia virus Gag p9 in viral budding and infection.
Article in Journal of virology, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed.
- Neutral sphingomyelinase 2 is required for HIV-1 maturation.Proceedings of the National Academy of Sciences of the United States of America · 2023Article
- Post-Translational Modifications of Retroviral HIV-1 Gag Precursors: An Overview of Their Biological Role.International journal of molecular sciences · 2021Review
- In vitro and in vivo replication of influenza A H1N1 WSN33 viruses with different M1 proteins.The Journal of general virology · 2013Article
- Identification of the HIV-1 NC binding interface in Alix Bro1 reveals a role for RNA.Journal of virology · 2012Article
- Budding capability of the influenza virus neuraminidase can be modulated by tetherin.Journal of virology · 2011Article
- Autoprocessing of human immunodeficiency virus type 1 protease miniprecursor fusions in mammalian cells.AIDS research and therapy · 2010Article
- Cysteine 95 and other residues influence the regulatory effects of Histidine 69 mutations on Human Immunodeficiency Virus Type 1 protease autoprocessing.Retrovirology · 2010Article
- Modulation of human immunodeficiency virus type 1 protease autoprocessing by charge properties of surface residue 69.Journal of virology · 2009Article
- Regulation of APOBEC3 proteins by a novel YXXL motif in human immunodeficiency virus type 1 Vif and simian immunodeficiency virus SIVagm Vif.Journal of virology · 2009Article
- Distinct intracellular trafficking of equine infectious anemia virus and human immunodeficiency virus type 1 Gag during viral assembly and budding revealed by bimolecular fluorescence complementation assays.Journal of virology · 2007Article
- Receptor-mediated entry by equine infectious anemia virus utilizes a pH-dependent endocytic pathway.Journal of virology · 2005Article
- Equine infectious anemia virus Gag p9 function in early steps of virus infection and provirus production.Journal of virology · 2005Article
- Heterologous late-domain sequences have various abilities to promote budding of human immunodeficiency virus type 1.Journal of virology · 2005Article
- Late assembly motifs of human T-cell leukemia virus type 1 and their relative roles in particle release.Journal of virology · 2004Article
- Differential effects of actin cytoskeleton dynamics on equine infectious anemia virus particle production.Journal of virology · 2004Article
- Late domain-dependent inhibition of equine infectious anemia virus budding.Journal of virology · 2004Article
- Characterization of RNA elements that regulate gag-pol ribosomal frameshifting in equine infectious anemia virus.Journal of virology · 2003Article
- Equine infectious anemia virus utilizes host vesicular protein sorting machinery during particle release.Journal of virology · 2003Article
- Retroviruses have differing requirements for proteasome function in the budding process.Journal of virology · 2003Article
- Overlapping motifs (PTAP and PPEY) within the Ebola virus VP40 protein function independently as late budding domains: involvement of host proteins TSG101 and VPS-4.Journal of virology · 2003Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Previous studies utilizing Gag polyprotein budding assays with transfected cells reveal that the equine infectious anemia virus (EIAV) Gag p9 protein provides a late assembly function mediated by a critical Y(23)P(24)D(25)L(26) motif (L-domain) to release viral particles from the plasma membrane. To elucidate further the role of EIAV p9 in virus assembly and replication, we have examined the replication properties of a defined series of p9 truncation and site-directed mutations in the context of a reference infectious molecular proviral clone, EIAV(uk). Characterization of these p9 proviral mutants revealed new functional properties of p9 in EIAV replication, not previously elucidated by Gag polyprotein budding assays. The results of these studies demonstrated that only the N-terminal 31 amino acids of a total of 51 residues in the complete p9 protein were required to maintain replication competence in transfected equine cells; proviral mutants with p9 C-terminal truncations of 20 or fewer amino acids remained replication competent, while mutants with truncations of 21 or more residues were completely replication defective. The inability of the defective p9 proviral mutations to produce infectious virus could not be attributed to defects in Gag polyprotein expression or processing, in virion RT activity, or in virus budding. While proviral replication competence appeared to be associated with the presence of a K(30)K(31) motif and potential ubiquitination of the EIAV p9 protein, mutations of these lysine residues to methionines produced variant proviruses that replicated as well as the parental EIAV(uk) in transfected ED cells. Thus, these observations reveal for the first time that EIAV p9 is not absolutely required for virus budding in the context of proviral gene expression, suggesting that other EIAV proteins can at least in part mediate late budding functions previously associated with the p9 protein. In addition, the data define a function for EIAV p9 in the infectivity of virus particles, indicating a previously unrecognized role for this Gag protein in EIAV replication.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.